OPKO Health's ModeX begins phase 1 trial of COVID-19 prevention drug
Go back to OPKO Health's ModeX begins phase 1 trial of COVID-19 prevention drug| OPKO HEALTH, Inc. (NASDAQ: OPK) | Delayed: 1.42 -0.03 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.45 | 52 Week High | $11.85 | |||
| Open | $1.45 | 52 Week Low | $7.12 | |||
| Day High | $1.48 | P/E | N/A | |||
| Day Low | $1.42 | EPS | $-0.30 | |||
| Volume | 1,762,766 | |||||
